C
CHRS
Coherus
1.680
+0.030+1.82%After Hours: 1.670 -0.010 -0.60%19:10 04/10 EDT
OPEN/PREV CLOSE1.640/1.650
TODAY RANGE1.640-1.690
VOL556.77K
MARKET CAP251.82M
52 WEEK RANGE0.7100-2.616
AVG VOL (3M)2.13M
% TURNOVER0.37%
TURNOVER--
P/E (TTM)1.171
% RANGE3.03%
EPS(TTM)1.434
P/E(FORWARD)-1.4876
P/B3.336
BVPS0.5036
DIVIDEND--
P/S4.826
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP208.40M
SHARES OUTSTANDING149.89M
NEXT EARNINGS05/11-05/15
FREE FLOAT124.05M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
Reuters·2d ago
Coherus Oncology announces annual shareholder meeting
TipRanks·04/03 00:14
Coherus BioSciences Charts Leaner Path After Earnings Call
Benzinga·03/30 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
TipRanks·03/10 10:26
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
Seeking Alpha·03/10 00:58
Coherus outlines $175M annualized LOQTORZI target by 2028 as commercial expansion accelerates
TipRanks·03/09 20:40
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
Reuters·03/09 20:31
CORRECTED-Coherus Oncology Q4 revenue misses estimates
Seeking Alpha·03/09 20:23
Coherus BioSciences Non-GAAP EPS of -$0.34 misses by $0.03, revenue of $12.7M misses by $1.39M
Benzinga·03/09 20:18
Insights into Coherus Oncology Q4 Earnings
Same Industry
Name/Symbol
Change%
Price